JESSICA CRISTINI: Open Payments
NPI 1528628328 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 14 payments from 10 companies in 2025. Trend: 2023 $1,469 · 2024 $1,293 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $147 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| CeQur Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
Products named: Dexcom G6 Transmitter, MOUNJARO, UNITHROID, Korlym, EVENITY, JARDIANCE, RECORLEV, CeQur Simplicity.
Industry payments across OH — which companies pay providers there.
